… that decreases monthly migraine and headache days in resistant chronic migraine.…
chronic migraine
This disease is selected. Its supporting articles are shown below.
Articles mentioning chronic migraine
15 articles · page 1 of 2…elevance Results suggest that the effectiveness of atogepant in chronic migraine, in terms of reducing monthly migraine days, is comparable betw…
…onists represent a major advance in the preventive treatment of chronic migraine, particularly for patients who have not responded to convention…
…Background Refractory headache disorders, including chronic migraine and selected secondary headache syn…
…f gepants (atogepant and rimegepant) in patients diagnosed with CM and HFEM naive versus those previously treated with anti-CGRP m…
…high-frequency episodic migraine (rimegepant and atogepant) and chronic migraine (atogepant), according to the ADVANCE and PROGRESS clinical tri…
…eviously received fremanezumab; 80% (n=24) had CM and 20% (n=6) HFEM. Median treatment duration was 5 months (1–13). Twelve patients…
…t using IBM SPSS.Results Thirty-eight patients (89% women) with CM (95%) and HFEM (5%) were included, with a median age of 45 [ran…
…lated peptide(CGRP) antagonists have recently been approved for chronic migraine(CM) and high-frequency episodic migraine(HFEM) prophylaxis.Aim …
…st calcitonin gene-related peptide (anti-CGRP) in patients with chronic or episodic migraine after completion of a first therapeutic cycle.Material and Meth…
…First line prophylaxis for Chronic Migraine (CM) includes tricyclics, betablockers, topiramate and candesar…
…se venous sinus thrombosis (VST) three years prior which led to chronic migraine. The headache worsened with posture, movement and valsalva mano…